{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:54:34Z","timestamp":1762955674870},"reference-count":23,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"vor","delay-in-days":336,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"DOI":"10.1093\/database\/baw062","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:18:59Z","timestamp":1485994739000},"source":"Crossref","is-referenced-by-count":7,"title":["ToxEvaluator: an integrated computational platform to aid the interpretation of toxicology study-related findings"],"prefix":"10.1093","volume":"2016","author":[{"given":"D.","family":"Pelletier","sequence":"first","affiliation":[{"name":"Pfizer Worldwide Research & Development, Groton, CT 06340"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. C.","family":"Wiegers","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Enayetallah","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kibbey","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research & Development, Groton, CT 06340"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gosink","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research & Development, Groton, CT 06340"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Koza-Taylor","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research & Development, Groton, CT 06340"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"Mattingly","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lawton","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research & Development, Groton, CT 06340"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,5,8]]},"reference":[{"key":"key\n\t\t\t\t20180618195141_baw062-B1","first-page":"181","article-title":"Evaluating the human relevance of chemically induced animal tumors.","volume":"78","author":"Cohen","year":"2004","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t20180618195141_baw062-B2","first-page":"247","article-title":"Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-alpha pharmacology.","volume":"131","author":"Erickson","year":"2013","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t20180618195141_baw062-B3","first-page":"391","article-title":"High-throughput kinase profiling as a platform for drug discovery.","volume":"7","author":"Goldstein","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20180618195141_baw062-B4","first-page":"D1100","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery.","volume":"40(Database issue)","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618195141_baw062-B5","first-page":"1124","article-title":"Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.","volume":"46","author":"Glick, M","year":"2006","journal-title":"J. Chem. Inf. Model"},{"key":"key\n\t\t\t\t20180618195141_baw062-B6","first-page":"363","article-title":"Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening.","volume":"3","author":"Xue","year":"2000","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"key\n\t\t\t\t20180618195141_baw062-B7","first-page":"4183","article-title":"Searching techniques for databases of two- and three-dimensional chemical structures.","volume":"48","author":"Willett","year":"2005","journal-title":"J. Med. Chem"},{"key":"key\n\t\t\t\t20180618195141_baw062-B8","first-page":"564","article-title":"A new face and new challenges for Online Mendelian Inheritance in Man (OMIM(R)).","volume":"32","author":"Amberger","year":"2011","journal-title":"Hum. Mutat"},{"key":"key\n\t\t\t\t20180618195141_baw062-B9","first-page":"D36","article-title":"Gene: a gene-centered information resource at NCBI.","volume":"43(Database issue)","author":"Brown","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618195141_baw062-B10","first-page":"285","article-title":"Allele, phenotype and disease data at Mouse Genome Informatics: improving access and analysis.","volume":"26","author":"Bello","year":"2015","journal-title":"Mamm. Genome"},{"key":"key\n\t\t\t\t20180618195141_baw062-B11","first-page":"D1049","article-title":"Gene Ontology Consortium: going forward.","volume":"43(Database issue)","author":"Gene Ontology","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618195141_baw062-B12","first-page":"317","article-title":"Medical subject headings used to search the biomedical literature.","volume":"8","author":"Coletti","year":"2001","journal-title":"J. Am. Med. Inform. Assoc"},{"key":"key\n\t\t\t\t20180618195141_baw062-B13","first-page":"D914","article-title":"The Comparative Toxicogenomics Database's 10th year anniversary: update 2015.","volume":"43(Database issue)","author":"Davis","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618195141_baw062-B14","first-page":"bat080.","article-title":"A CTD-Pfizer collaboration: manual curation of 88,000 scientific articles text mined for drug-disease and drug-phenotype interactions.","volume":"2013","author":"Davis","year":"2013","journal-title":"Database (Oxford)"},{"key":"key\n\t\t\t\t20180618195141_baw062-B15","first-page":"e46524.","article-title":"Ranking transitive chemical-disease inferences using local network topology in the comparative toxicogenomics database.","volume":"7","author":"King","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180618195141_baw062-B16","first-page":"31","article-title":"SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules.","volume":"28","author":"Weininger","year":"1988","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"key\n\t\t\t\t20180618195141_baw062-B17","first-page":"D319","article-title":"The HUGO Gene Nomenclature Database, 2006 updates.","volume":"34(Database issue)","author":"Eyre","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618195141_baw062-B18","first-page":"79","article-title":"Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.","volume":"81","author":"Lahaye","year":"2014","journal-title":"Joint Bone Spine"},{"key":"key\n\t\t\t\t20180618195141_baw062-B19","first-page":"445","article-title":"Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats.","volume":"36","author":"Obayashi","year":"2011","journal-title":"J. Toxicol. Sci"},{"key":"key\n\t\t\t\t20180618195141_baw062-B20","first-page":"90","article-title":"Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy.","volume":"39","author":"Sidaway","year":"2009","journal-title":"Xenobiotica"},{"key":"key\n\t\t\t\t20180618195141_baw062-B21","first-page":"1609","article-title":"The SLCO1B1*5 genetic variant is associated with statin-induced side effects.","volume":"54","author":"Voora","year":"2009","journal-title":"J. Am. Coll. Cardiol"},{"key":"key\n\t\t\t\t20180618195141_baw062-B22","first-page":"233","article-title":"Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.","volume":"12","author":"Brunham","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"key\n\t\t\t\t20180618195141_baw062-B23","first-page":"565","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin. Pharmacol. Ther"}],"container-title":["Database"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baw062\/17473909\/baw062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T23:54:46Z","timestamp":1529366086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/baw062\/2630387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":23,"URL":"https:\/\/doi.org\/10.1093\/database\/baw062","relation":{},"ISSN":["1758-0463"],"issn-type":[{"value":"1758-0463","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016]]},"published":{"date-parts":[[2016,1,1]]}}}